Does LEDIPASVIR\SOFOSBUVIR Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 0.0% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.
6
Reports of Malignant neoplasm progression with LEDIPASVIR\SOFOSBUVIR
0.0%
of all LEDIPASVIR\SOFOSBUVIR reports
2
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LEDIPASVIR\SOFOSBUVIR?
Of the 6 reports, 2 (33.3%) resulted in death, 2 (33.3%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?
Fatigue (4,609)
Headache (4,203)
Nausea (1,471)
Drug ineffective (1,397)
Hepatitis c (1,076)
Diarrhoea (1,065)
Insomnia (1,021)
Hepatocellular carcinoma (640)
Vomiting (623)
Dizziness (604)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Malignant neoplasm progression Risk?
LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE
LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT
LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR
LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE
LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB